154 related articles for article (PubMed ID: 38367508)
1. Vaccine-induced neutralizing antibodies bind to the H protein of a historical measles virus.
Zemella A; Beer K; Ramm F; Wenzel D; Düx A; Merkel K; Calvignac-Spencer S; Stern D; Dorner MB; Dorner BG; Widulin N; Schnalke T; Walter C; Wolbert A; Schmid BG; Mankertz A; Santibanez S
Int J Med Microbiol; 2024 Mar; 314():151607. PubMed ID: 38367508
[TBL] [Abstract][Full Text] [Related]
2. Measles Virus Hemagglutinin epitopes immunogenic in natural infection and vaccination are targeted by broad or genotype-specific neutralizing monoclonal antibodies.
Muñoz-Alía MA; Casasnovas JM; Celma ML; Carabaña J; Liton PB; Fernandez-Muñoz R
Virus Res; 2017 May; 236():30-43. PubMed ID: 28465158
[TBL] [Abstract][Full Text] [Related]
3. Epitope dampening monotypic measles virus hemagglutinin glycoprotein results in resistance to cocktail of monoclonal antibodies.
Lech PJ; Tobin GJ; Bushnell R; Gutschenritter E; Pham LD; Nace R; Verhoeyen E; Cosset FL; Muller CP; Russell SJ; Nara PL
PLoS One; 2013; 8(1):e52306. PubMed ID: 23300970
[TBL] [Abstract][Full Text] [Related]
4. Antigenic Drift Defines a New D4 Subgenotype of Measles Virus.
Muñoz-Alía MÁ; Muller CP; Russell SJ
J Virol; 2017 Jun; 91(11):. PubMed ID: 28356529
[TBL] [Abstract][Full Text] [Related]
5. Generation of a More Immunogenic Measles Vaccine by Increasing Its Hemagglutinin Expression.
Julik E; Reyes-Del Valle J
J Virol; 2016 Jun; 90(11):5270-5279. PubMed ID: 26984727
[TBL] [Abstract][Full Text] [Related]
6. A chimeric alphavirus replicon particle vaccine expressing the hemagglutinin and fusion proteins protects juvenile and infant rhesus macaques from measles.
Pan CH; Greer CE; Hauer D; Legg HS; Lee EY; Bergen MJ; Lau B; Adams RJ; Polo JM; Griffin DE
J Virol; 2010 Apr; 84(8):3798-807. PubMed ID: 20130066
[TBL] [Abstract][Full Text] [Related]
7. Functional and structural characterization of neutralizing epitopes of measles virus hemagglutinin protein.
Tahara M; Ito Y; Brindley MA; Ma X; He J; Xu S; Fukuhara H; Sakai K; Komase K; Rota PA; Plemper RK; Maenaka K; Takeda M
J Virol; 2013 Jan; 87(1):666-75. PubMed ID: 23115278
[TBL] [Abstract][Full Text] [Related]
8. Measles viruses of genotype H1 evade recognition by vaccine-induced neutralizing antibodies targeting the linear haemagglutinin noose epitope.
Finsterbusch T; Wolbert A; Deitemeier I; Meyer K; Mosquera MM; Mankertz A; Santibanez S
J Gen Virol; 2009 Nov; 90(Pt 11):2739-2745. PubMed ID: 19625457
[TBL] [Abstract][Full Text] [Related]
9. Successful vaccine-induced seroconversion by single-dose immunization in the presence of measles virus-specific maternal antibodies.
Schlereth B; Rose JK; Buonocore L; ter Meulen V; Niewiesk S
J Virol; 2000 May; 74(10):4652-7. PubMed ID: 10775601
[TBL] [Abstract][Full Text] [Related]
10. Antibody neutralization of retargeted measles viruses.
Lech PJ; Pappoe R; Nakamura T; Tobin GJ; Nara PL; Russell SJ
Virology; 2014 Apr; 454-455():237-46. PubMed ID: 24725950
[TBL] [Abstract][Full Text] [Related]
11. Probing neutralizing-antibody responses against emerging measles viruses (MVs): immune selection of MV by H protein-specific antibodies?
Santibanez S; Niewiesk S; Heider A; Schneider-Schaulies J; Berbers GAM; Zimmermann A; Halenius A; Wolbert A; Deitemeier I; Tischer A; Hengel H
J Gen Virol; 2005 Feb; 86(Pt 2):365-374. PubMed ID: 15659756
[TBL] [Abstract][Full Text] [Related]
12. A hemagglutinin-derived peptide-vaccine ignored by virus-neutralizing passive antibodies, protects against murine measles encephalitis.
El Kasmi KC; Theisen D; Brons NH; Ammerlaan W; Klingele M; Truong AT; Muller CP
Vaccine; 1999 May; 17(19):2436-45. PubMed ID: 10392626
[TBL] [Abstract][Full Text] [Related]
13. Attenuated Salmonella enterica serovar Typhi and Shigella flexneri 2a strains mucosally deliver DNA vaccines encoding measles virus hemagglutinin, inducing specific immune responses and protection in cotton rats.
Pasetti MF; Barry EM; Losonsky G; Singh M; Medina-Moreno SM; Polo JM; Ulmer J; Robinson H; Sztein MB; Levine MM
J Virol; 2003 May; 77(9):5209-17. PubMed ID: 12692223
[TBL] [Abstract][Full Text] [Related]
14. Protective immunity in macaques vaccinated with a modified vaccinia virus Ankara-based measles virus vaccine in the presence of passively acquired antibodies.
Stittelaar KJ; Wyatt LS; de Swart RL; Vos HW; Groen J; van Amerongen G; van Binnendijk RS; Rozenblatt S; Moss B; Osterhaus AD
J Virol; 2000 May; 74(9):4236-43. PubMed ID: 10756037
[TBL] [Abstract][Full Text] [Related]
15. Induction of type I interferon secretion through recombinant Newcastle disease virus expressing measles virus hemagglutinin stimulates antibody secretion in the presence of maternal antibodies.
Kim D; Martinez-Sobrido L; Choi C; Petroff N; García-Sastre A; Niewiesk S; Carsillo T
J Virol; 2011 Jan; 85(1):200-7. PubMed ID: 20962092
[TBL] [Abstract][Full Text] [Related]
16. Lentiviral vectors displaying modified measles virus gp overcome pre-existing immunity in in vivo-like transduction of human T and B cells.
Lévy C; Amirache F; Costa C; Frecha C; Muller CP; Kweder H; Buckland R; Cosset FL; Verhoeyen E
Mol Ther; 2012 Sep; 20(9):1699-712. PubMed ID: 22617109
[TBL] [Abstract][Full Text] [Related]
17. Measles Virus Hemagglutinin Protein Epitopes: The Basis of Antigenic Stability.
Tahara M; Bürckert JP; Kanou K; Maenaka K; Muller CP; Takeda M
Viruses; 2016 Aug; 8(8):. PubMed ID: 27490564
[TBL] [Abstract][Full Text] [Related]
18. Serotypic evolution of measles virus is constrained by multiple co-dominant B cell epitopes on its surface glycoproteins.
Muñoz-Alía MÁ; Nace RA; Zhang L; Russell SJ
Cell Rep Med; 2021 Apr; 2(4):100225. PubMed ID: 33948566
[TBL] [Abstract][Full Text] [Related]
19. Protective immunity provided by HLA-A2 epitopes for fusion and hemagglutinin proteins of measles virus.
Oh S; Stegman B; Pendleton CD; Ota MO; Pan CH; Griffin DE; Burke DS; Berzofsky JA
Virology; 2006 Sep; 352(2):390-9. PubMed ID: 16781760
[TBL] [Abstract][Full Text] [Related]
20. Plant-derived measles virus hemagglutinin protein induces neutralizing antibodies in mice.
Huang Z; Dry I; Webster D; Strugnell R; Wesselingh S
Vaccine; 2001 Feb; 19(15-16):2163-71. PubMed ID: 11228389
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
